---
title: "Evelo Biosciences (EVLO.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EVLO.US/norm.md"
symbol: "EVLO.US"
name: "Evelo Biosciences"
parent: "https://longbridge.com/en/quote/EVLO.US.md"
datetime: "2026-03-14T12:16:10.952Z"
locales:
  - [en](https://longbridge.com/en/quote/EVLO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EVLO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EVLO.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/EVLO.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/EVLO.US/norm.md)


# Evelo Biosciences (EVLO.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.7112 | -3.78 | -4.57 | -4.29 | -5.66 |
| ROE | 135.81% | 229.65% | 626.09% | -4337.36% | -543.58% |
| Revenue | - | - | - | - | - |
| Net income | -12.36M | -21.10M | -25.34M | -23.54M | -30.56M |
| Operating income | -10.39M | -17.46M | -24.90M | -21.09M | -29.05M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| --- | --- | --- | --- | --- | --- |
| A&L | 20.63M | 20.82M | 41.97M | 64.44M | 86.34M |
| Leverage | -0.7723 | -0.4514 | -1.53 | -12.91 | 9.25 |
| BVPS | -1.42 | -8.24 | -4.94 | -0.9007 | 1.72 |
| Turnover | - | - | - | - | - |
| Cash & STI | 17.26M | 7.62M | 27.47M | 47.94M | 69.05M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 894000.00 | 8.13M | 10.73M | 11.71M | 12.85M |
| Net debt | 16.69M | 42.86M | 23.22M | 3.20M | -14.20M |

## Cash Flow Statement (USD)

| Indicator | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -10.41M | -19.83M | -20.28M | -23.19M | -22.59M |
| Investing CF | 513000.00 | 0.0000 | -12000.00 | -228000.00 | -9000.00 |
| Financing CF | 19.22M | 0.0000 | -199000.00 | 1.74M | 665000.00 |
| Free CF | -5.05M | -11.35M | -10.20M | -14.33M | -11.25M |
| OCF coverage | -204.24% | - | -168966.67% | -48.48% | -250966.67% |
| Repaid & issued | - | - | - | 44.49M | - |
| CapEx | -47000.00 | 0.0000 | -12000.00 | -228000.00 | -9000.00 |